YKS(SZ:300209)2025-09-22 06:02Group 1: Financial Performance - The company's R&D expenses for the first half of 2025 were zero, compared to 2.62 million in the same period last year, indicating a significant reduction in R&D activities [1] - The cross-border e-commerce business further shrank in the first half of 2025 due to ongoing financial pressures [1] - The company expects to disclose its Q3 report by October 31, 2025, and aims to exceed 100 million in revenue for the year [1][2] Group 2: Corporate Governance and Restructuring - The company has issued a notice for the first extraordinary general meeting of 2025, indicating ongoing governance changes [2] - The major shareholder's reconciliation and potential control over the company are under scrutiny, with asset injection conditions being discussed [2] - The company is committed to ensuring that major shareholders adhere to the restructuring plan and expedite the injection of quality assets and businesses [2][3] Group 3: Strategic Initiatives - The current board has not completed its election process, but it continues to oversee the adherence to the restructuring plan [3] - The company is focused on changing its image and performance, particularly following the departure of previous management [3] - There are ongoing discussions about the potential asset injection from the major shareholder, with no specific timeline provided yet [3]